Pfizer Settles First of 2,600 Claims Regarding Chantix and Suicide

By
-
0
100

After failing to win a postponement earlier this week, Pfizer settled with the widow of Minnesota man who suicided while using the stop-smoking drug Chantix. Approximately 2,600 claims regarding suicides, attempted suicides and other psychiatric conditions nationwide are still pending in an Alabama court.

Article → Related article:
Facing Monday trial, Pfizer settles bellwether Chantix case

Previous articleSSRIs Increase Risk of Brain Hemorrhage
Next articleGenetic Markers do not Predict Response to Antidepressants
Kermit Cole
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

LEAVE A REPLY